These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 8743335)

  • 21. A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function.
    Duong JK; Kroonen MYAM; Kumar SS; Heerspink HL; Kirkpatrick CM; Graham GG; Williams KM; Day RO
    Eur J Clin Pharmacol; 2017 Aug; 73(8):981-990. PubMed ID: 28451709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contraindications can damage your health--is metformin a case in point?
    Holstein A; Stumvoll M
    Diabetologia; 2005 Dec; 48(12):2454-9. PubMed ID: 16283245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
    Herman GA; Bergman A; Yi B; Kipnes M;
    Curr Med Res Opin; 2006 Oct; 22(10):1939-47. PubMed ID: 17022853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nephrotoxicity after the use of intravenous X-ray contrast media in a type 2 diabetic being treated with metformin].
    Bjarnason NH; Elung-Jensen T
    Ugeskr Laeger; 2006 May; 168(18):1772-3. PubMed ID: 16729932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment.
    Bruijstens LA; van Luin M; Buscher-Jungerhans PM; Bosch FH
    Neth J Med; 2008 May; 66(5):185-90. PubMed ID: 18490795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of organic cation transporter 3 (Oct3/Slc22a3) in the bioavailability and pharmacokinetics of antidiabetic metformin in mice.
    Shirasaka Y; Lee N; Zha W; Wagner D; Wang J
    Drug Metab Pharmacokinet; 2016 Oct; 31(5):385-388. PubMed ID: 27569291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin-associated lactic acidosis treated with continuous renal replacement therapy.
    Alivanis P; Giannikouris I; Paliuras C; Arvanitis A; Volanaki M; Zervos A
    Clin Ther; 2006 Mar; 28(3):396-400. PubMed ID: 16750454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
    Choi YH; Kim SG; Lee MG
    J Pharm Sci; 2006 Nov; 95(11):2543-52. PubMed ID: 16937336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants.
    Devineni D; Manitpisitkul P; Murphy J; Skee D; Wajs E; Mamidi RN; Tian H; Vandebosch A; Wang SS; Verhaeghe T; Stieltjes H; Usiskin K
    Clin Pharmacol Drug Dev; 2015; 4(3):226-36. PubMed ID: 27140803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin hydrochloride: an antihyperglycemic agent.
    Klepser TB; Kelly MW
    Am J Health Syst Pharm; 1997 Apr; 54(8):893-903. PubMed ID: 9114921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unexpectedly long half-life of metformin elimination in cases of metformin accumulation.
    Kajbaf F; Bennis Y; Hurtel-Lemaire AS; Andréjak M; Lalau JD
    Diabet Med; 2016 Jan; 33(1):105-10. PubMed ID: 26337524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin induced lactic acidosis--particularities and course.
    Strugaru AM; Botnariu G; Agoroaei L; Grigoriu IC; Butnaru E
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(4):1035-42. PubMed ID: 24502087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosiglitazone does not alter the pharmacokinetics of metformin.
    Di Cicco RA; Allen A; Carr A; Fowles S; Jorkasky DK; Freed MI
    J Clin Pharmacol; 2000 Nov; 40(11):1280-5. PubMed ID: 11075314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin-naïve type 2 diabetes.
    Dissanayake AM; Wheldon MC; Hood CJ
    Pharmacol Res Perspect; 2018 Oct; 6(5):e00424. PubMed ID: 30221006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of metformin: variability due to polymorphisms of organic cation transporters.
    Zolk O
    Ann Med; 2012 Mar; 44(2):119-29. PubMed ID: 21366511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure.
    Di Grande A; Vancheri F; Giustolisi V; Giuffrida C; Narbone G; Licata M; Le Moli C; Riccobene S; Burgio A; Bartolotta S; Nigro F; Cannone V
    Clin Ter; 2008; 159(2):87-9. PubMed ID: 18463766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects.
    Robert F; Fendri S; Hary L; Lacroix C; Andréjak M; Lalau JD
    Diabetes Metab; 2003 Jun; 29(3):279-83. PubMed ID: 12909816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.